Arronax Nantes > Expérimentation préclinique et recherche clinique > Nos Publications > 2020 > Publication 2020 4
Publication 2020 4
Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials, Michaud-Robert A-V, Zamagni E, Carlier T, Bailly C, Jamet B, Touzeau C, et al, Cancers. 6 sept 2020;12(9):2532. https://doi.org/10.3390/cancers12092532